JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,495,000 | +34.7% | 50,000 | 0.0% | 0.01% | +44.4% |
| Q1 2017 | $1,110,000 | -26.4% | 50,000 | -37.5% | 0.01% | -40.0% |
| Q4 2016 | $1,508,000 | -37.2% | 80,000 | 0.0% | 0.02% | -31.8% |
| Q3 2016 | $2,401,000 | -21.9% | 80,000 | 0.0% | 0.02% | -31.2% |
| Q2 2016 | $3,075,000 | +0.9% | 80,000 | 0.0% | 0.03% | 0.0% |
| Q1 2016 | $3,047,000 | -13.4% | 80,000 | 0.0% | 0.03% | +10.3% |
| Q4 2015 | $3,518,000 | +8.1% | 80,000 | 0.0% | 0.03% | -3.3% |
| Q3 2015 | $3,255,000 | -23.7% | 80,000 | 0.0% | 0.03% | -18.9% |
| Q2 2015 | $4,266,000 | -29.7% | 80,000 | -20.0% | 0.04% | -26.0% |
| Q1 2015 | $6,066,000 | +16.2% | 100,000 | 0.0% | 0.05% | -5.7% |
| Q4 2014 | $5,222,000 | – | 100,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Biomark Capital Management Co. LLC | 1,864,174 | $83,627,000 | 94.97% |
| Crestline Management, LP | 9,348,799 | $419,387,000 | 58.30% |
| Omega Fund Management, LLC | 1,074,612 | $48,207,000 | 27.27% |
| PECONIC PARTNERS LLC | 570,000 | $25,570,000 | 4.12% |
| SIB LLC | 100,000 | $4,486,000 | 3.22% |
| Cormorant Asset Management, LP | 375,000 | $16,823,000 | 2.97% |
| BB BIOTECH AG | 2,055,000 | $92,187,000 | 2.55% |
| Clarius Group, LLC | 117,896 | $5,289,000 | 2.23% |
| Monashee Investment Management LLC | 122,000 | $5,473,000 | 2.07% |
| Iguana Healthcare Management, LLC | 150,000 | $6,730,000 | 1.86% |